Center Laboratories (ROCO:4123) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4123 Center Laboratories Inc ROCO:4123
69 GF Score
Price NT$37.50
GF Value NT$43.04
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Center Laboratories Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ROCO:4123 vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Center Laboratories's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Center Laboratories Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Center Laboratories's Short Interest distribution charts can be found below:

* The bar in red indicates where Center Laboratories's Short Interest falls into.


ROCO:4123
69GF Score
Center Laboratories Inc ROCO:4123
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Center Laboratories (ROCO:4123) Overvalued in 2026?

Based on GuruFocus' analysis, Center Laboratories stock appears to be undervalued. The current stock price of NT$37.50 is trading 12.9% below its estimated GF Value™ of NT$43.04. GuruFocus considers Center Laboratories to be Modestly Undervalued.

Key valuation signals for ROCO:4123:

  • Short Interest:
  • GF Value™: NT$43.04 vs. price of NT$37.50 (12.9% below fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the ROCO:4123 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Center Laboratories Business Description

Address No. 3-2, Park Street, 7th floor, Nangang District, Taipei City, TWN, 115
Center Laboratories Inc is engaged in the manufacture and sale of various Western pharmaceuticals, including Western medicine manufacturing, wholesale, and retail. The Company operates through the following segments: Pharmaceutical Division, Biotechnology Venture Capital, and Glac Segment. The Pharmaceutical Division, which generates the majority of revenue, manufactures and sells various Western pharmaceuticals. The Biotechnology Venture Capital segment invests in domestic and foreign biotechnology undertakings, while the Glac Segment manufactures and sells probiotic products. The Company operates in Taiwan, Mainland China, and other regions, with Taiwan generating the majority of revenue.
69GF Score

Get the complete analysis for ROCO:4123

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$37.50
Price
NT$43.04
GF Value